PECAM1 and carcinoma: Moreover, we clearly demonstrated that ZSTK474 suppressed the number of CD31-positive cells and inhibited blood vessel formation within the tumors, suggestive of an anti-angiogenic effect, in agreement with our previous finding using carcinoma cells [39].